Wealthfront Advisers LLC United Therapeutics Corp Transaction History
Wealthfront Advisers LLC
- $29.7 Billion
- Q2 2024
A detailed history of Wealthfront Advisers LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Wealthfront Advisers LLC holds 905 shares of UTHR stock, worth $306,776. This represents 0.0% of its overall portfolio holdings.
Number of Shares
905Holding current value
$306,776% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding UTHR
# of Institutions
619Shares Held
45MCall Options Held
368KPut Options Held
410K-
Black Rock Inc. New York, NY5.47MShares$1.85 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.42MShares$1.5 Billion0.03% of portfolio
-
Wellington Management Group LLP Boston, MA3.29MShares$1.11 Billion0.19% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.86MShares$969 Million12.43% of portfolio
-
State Street Corp Boston, MA2.29MShares$778 Million0.03% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $15.4B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...